Sharom F J, Yu X, Doige C A
Guelph-Waterloo Centre for Graduate Work in Chemistry, University of Guelph, Ontario, Canada.
J Biol Chem. 1993 Nov 15;268(32):24197-202.
P-glycoprotein, the multidrug transporter, is proposed to act as an ATP-driven drug efflux pump. We previously reported the partial purification of P-glycoprotein from multidrug-resistant cells (Doige, C. A., Yu, X., and Sharom, F. J. (1992) Biochim. Biophys. Acta 1109, 149-160). We now report the reconstitution of this preparation into phospholipid bilayers using rapid detergent removal by gel filtration chromatography. The resulting proteoliposomes displayed ATP-dependent [3H]colchicine uptake over a time period of 0-4 min. No drug uptake was observed for liposomes of lipid alone, or liposomes reconstituted with a similar extract from drug-sensitive cells. Drug uptake was osmotically sensitive, and abolished by detergent permeabilization, indicating that it represented true transport into the vesicle lumen. Steady-state levels of drug uptake increased with drug concentration, approaching saturation at approximately 150 microM colchicine, with half-maximal accumulation at 50 microM. Drug was accumulated actively against a 5.6-fold concentration gradient. Multidrug resistance spectrum drugs and chemosensitizers inhibited colchicine uptake by P-glycoprotein proteoliposomes, whereas cytosine arabinoside and methotrexate had no effect. Reconstituted liposomes showed high levels of ATPase activity, which was stimulated over 2-fold by verapamil and trifluoperazine. These results suggest that P-glycoprotein functions as an active drug transporter with constitutive ATPase activity.
多药转运蛋白P-糖蛋白被认为是一种由ATP驱动的药物外排泵。我们之前报道了从多药耐药细胞中部分纯化P-糖蛋白(Doige, C. A., Yu, X., and Sharom, F. J. (1992) Biochim. Biophys. Acta 1109, 149 - 160)。我们现在报道通过凝胶过滤色谱快速去除去污剂,将该制剂重组成磷脂双层。所得的蛋白脂质体在0 - 4分钟内显示出ATP依赖的[3H]秋水仙碱摄取。单独脂质的脂质体或用来自药物敏感细胞的类似提取物重组成的脂质体均未观察到药物摄取。药物摄取对渗透压敏感,并通过去污剂通透化而消除,表明它代表真正转运到囊泡腔内。药物摄取的稳态水平随药物浓度增加,在约150 microM秋水仙碱时接近饱和,在50 microM时达到最大积累量的一半。药物以5.6倍的浓度梯度被主动积累。多药耐药谱药物和化学增敏剂抑制P-糖蛋白蛋白脂质体对秋水仙碱的摄取,而阿糖胞苷和甲氨蝶呤则无影响。重组脂质体显示出高水平的ATP酶活性,维拉帕米和三氟拉嗪可将其刺激超过2倍。这些结果表明P-糖蛋白作为一种具有组成型ATP酶活性的活性药物转运蛋白发挥作用。